These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39259735)

  • 61. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions.
    Hermans S; Horsburgh CR; Wood R
    PLoS One; 2015; 10(8):e0135179. PubMed ID: 26288079
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.
    Martineau AR; Nhamoyebonde S; Oni T; Rangaka MX; Marais S; Bangani N; Tsekela R; Bashe L; de Azevedo V; Caldwell J; Venton TR; Timms PM; Wilkinson KA; Wilkinson RJ
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19013-7. PubMed ID: 22025704
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
    Tanue EA; Nsagha DS; Njamen TN; Assob NJC
    PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of COVID-19 on selected essential public health services - lessons learned from a retrospective record review in the Free State, South Africa.
    Heunis C; Chikobvu P; Muteba M; Kigozi-Male G; Engelbrecht M; Mushori P
    BMC Health Serv Res; 2023 Nov; 23(1):1244. PubMed ID: 37951875
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.
    Mnguni AT; Schietekat D; Ebrahim N; Sonday N; Boliter N; Schrueder N; Gabriels S; Sigwadhi LN; Zemlin AE; Chapanduka ZC; Ngah V; Yalew A; Jalavu T; Abdullah I; Tamuzi JL; Tembo Y; Davies MA; English R; Nyasulu PS
    BMC Infect Dis; 2023 Feb; 23(1):123. PubMed ID: 36855103
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Complementary surveillance strategies are needed to better characterise the epidemiology, care pathways and treatment outcomes of tuberculosis in children.
    du Preez K; Schaaf HS; Dunbar R; Walters E; Swartz A; Solomons R; Hesseling AC
    BMC Public Health; 2018 Mar; 18(1):397. PubMed ID: 29566651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantification and correlates of tuberculosis stigma along the tuberculosis testing and treatment cascades in South Africa: a cross-sectional study.
    Bresenham D; Kipp AM; Medina-Marino A
    Infect Dis Poverty; 2020 Oct; 9(1):145. PubMed ID: 33092636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa.
    Kassanjee R; Davies MA; Ngwenya O; Osei-Yeboah R; Jacobs T; Morden E; Timmerman V; Britz S; Mendelson M; Taljaard J; Riou J; Boulle A; Tiffin N; Zinyakatira N
    J Int AIDS Soc; 2023 Jun; 26(6):e26104. PubMed ID: 37339333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis.
    Harrington KRV; Gandhi NR; Shah NS; Naidoo K; Auld SC; Andrews JR; Brust JCM; Lutchminarain K; Coe M; Willis F; Campbell A; Cohen T; Jenness SM; Waller LA;
    Ann Epidemiol; 2024 Sep; 97():44-51. PubMed ID: 39038747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical evolution, management and outcomes of patients with COVID-19 admitted at Tygerberg Hospital, Cape Town, South Africa: a research protocol.
    Allwood BW; Koegelenberg CF; Irusen E; Lalla U; Davids R; Chothia Y; Davids R; Prozesky H; Taljaard J; Parker A; Decloedt E; Jordan P; Lahri S; Moosa R; Schrueder N; Du Toit R; Viljoen A; English R; Ayele B; Nyasulu P;
    BMJ Open; 2020 Aug; 10(8):e039455. PubMed ID: 32868368
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
    Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
    AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa.
    Parker A; Koegelenberg CFN; Moolla MS; Louw EH; Mowlana A; Nortjé A; Ahmed R; Brittain N; Lalla U; Allwood BW; Prozesky H; Schrueder N; Taljaard JJ
    S Afr Med J; 2020 Aug; 110(10):982-987. PubMed ID: 33205724
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study.
    Swanepoel J; van der Zalm MM; Preiser W; van Zyl G; Whittaker E; Hesseling AC; Moore DAJ; Seddon JA
    BMC Infect Dis; 2023 Jun; 23(1):442. PubMed ID: 37386354
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
    Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
    EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
    Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
    Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of directly observed treatment short course (DOTS) on treatment of tuberculosis patients in public health facilities of Debre Tabor Town, Ethiopia: retrospective study.
    Genet C; Melese A; Worede A
    BMC Res Notes; 2019 Jul; 12(1):396. PubMed ID: 31300032
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.